Get started
Author

Dimitrios Andreikos

Observed name: D. Andreikos
ORCID: 0000-0002-5148-3837
Observed ORCID: 0000-0002-5148-3837
OpenAlex ID: A5106607352
Statins’ still controversial role in pulmonary fibrosis: What does the evidence show?
2022 · Dimitrios Andreikos, Theodoros Karampitsakos, et al. · Pulmonary Pharmacology & Therapeutics · 14
Cannabis use and its impact on respiratory physiology and lung cancer risk: Mechanistic and epidemiological insights (Review)
2025 · Vasiliki Georgakopoulou, Dimitrios Andreikos, et al. · Biomedical Reports · 5
PDF
Endocrine paraneoplastic syndromes in lung cancer: A call for clinical vigilance (Review)
2025 · Maria-Evangelia Koloutsou, Maria Soura, et al. · Molecular and Clinical Oncology · 4
PDF
The Association between Telomere Length and Head and Neck Cancer Risk: A Systematic Review and Meta-Analysis
2024 · Dimitrios Andreikos, Efthymios Kyrodimos, et al. · International Journal of Molecular Sciences · 4
PDF
Telomere length and skin cancer risk: A systematic review and meta‑analysis of melanoma, basal cell carcinoma and squamous cell carcinoma
2025 · Dimitrios Andreikos, Demetrios Spandidos · Oncology Letters · 3
PDF
Telomeres and telomerase in mesothelioma: Pathophysiology, biomarkers and emerging therapeutic strategies (Review)
2025 · Dimitrios Andreikos, Demetrios Spandidos, et al. · International Journal of Oncology · 3
PDF
Arsenic exposure and skin cancer: Mechanisms, clinical evidence and public health implications (Review)
2026 · Dimitrios Andreikos, Michael Aschner, et al. · International Journal of Molecular Medicine · 1
P06-12 Heavy metals and skin cancer: From pathophysiology to public health
2025 · D. Andreikos, M. Aschner, et al. · Toxicology Letters
Works count: 8
Citation count: 34
H-index: 4
I10-index: 1
Year
Topic
Type